Option chain shows key data for Range Capital Acquisition's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Range Capital Acquisition.

Range Capital Acquisition (NASDAQ:RANGU) Stock, Option Chain

Range Capital Acquisition Corp is a blank check company.

Range Capital Acquisition Corp

Biotech

News

General

ProMIS Neurosciences Doses First Patients In Its Phase 1b PRECISE-AD Trial Of PMN310 In Alzheimer's Disease

Baird analyst Michael Bellisario maintains Choice Hotels Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHH#NYSE">CHH</a>) with a Outperform and raises the price target from $145 to $160.

Price Target

Analyst Ratings

Baird Maintains Outperform on Choice Hotels Intl, Raises Price Target to $160

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in exchange for a high-single digit royalty on worldwide sales of D-Fi. The syndicate includes existing Castle Creek investors Paragon Biosciences and Valor Equity Partners and new investor XOMA Royalty Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>).

Health Care

Financing

LGND

XOMA

Ligand Pharmaceuticals Closed A Royalty Financing Agreement With Castle Creek Biosciences, Inc. To Support The Phase 3 Study Of D-Fi (FCX-007), Castle Creek's Lead Candidate, In Patients With Dystrophic Epidermolysis Bullosa

E-commerce player Amazon.com Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) quarterly revenue surpassed retail giant Walmart Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) sales in the fourth quarter for the first time since 2000. Jeff Bezos said in 2018 that every overnight success takes at least 10 years, but this particular milestone took 25 years.
What Happened: Both <a href="https://www.benzinga.com/25/02/43545590/amazoncom-q4-earnings-highlights-revenue-beat-eps-beat-most-successful-holiday-shopping-season-in-company-history">Amazon</a> and <a href="https://www.benzinga.com/news/earnings/25/02/43846469/walmart-q4-earnings-shine-but-soft-fy26-outlook-disappoints-street">Walmart</a> reported strong fourth-quarter results, exceeding analyst expectations. Amazon&#8217;s net sales reached $187.8 billion with $1.86 EPS, while Walmart&#8217;s sales hit $180.55 billion with $0.66 adjusted EPS, both demonstrating growth and outperforming consensus estimates. 
Charlie Bilello, the chief market strategist at Creative Planning highlighted in an X post how Amazon's revenue has gradually grown over the years.
From making 77 times lower in quarterly sales as compared to the retail giant Walmart in the year 2000 to exceeding the former in terms of revenue earned in the fourth quarter of fiscal year 2025, Amazon has had a long journey.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">25 yrs ago: Walmart revenue 77x larger than Amazon 15 yrs ago: Walmart revenue 12x larger than Amazon 10 yrs ago: Walmart revenue 5x larger than Amazon 5 yrs ago: Walmart revenue 2x larger than Amazon Today: Amazon revenue &gt; Walmart revenue<a href="https://twitter.com/search?q=%24AMZN&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AMZN</a> <a href="https://twitter.com/search?q=%24WMT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$WMT</a> <a href="https://t.co/PiDKnmCEu5">pic.twitter.com/PiDKnmCEu5</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1893734565048459566?ref_src=twsrc%5Etfw">February 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/02/43933428/dominos-pizza-serves-consistent-market-share-gains-since-2015-despite-q4-earnings-miss-aims-for-3-same-store-sales-growth-to-capture-additional-share">Domino&#8217;s Pizza Sees 1% QSR Market Share Increase Despite Q4 Earnings Miss: &#8216;Consistent With Our Average Annual Share Growth&#8217;</a>
Why It Matters: &#8220;All overnight success takes about 10 years,&#8221; Bezos <a href="https://www.benzinga.com/startups/24/10/41255752/jeff-bezos-says-all-overnight-success-takes-10-years-amazon-didnt-turn-a-profit-for-almost-a-decade">said</a> in a 2018 CNBC interview. 
Bezos attributed Amazon&#8217;s success to a long-term, forward-thinking approach, recognizing that current results reflect decisions made in the years prior. According to him, <a href="https://www.benzinga.com/startups/24/10/41255752/jeff-bezos-says-all-overnight-success-takes-10-years-amazon-didnt-turn-a-profit-for-almost-a-decade">prioritizing innovation</a> and calculated risks over short-term profits, led to services like Prime and AWS.
Despite early financial losses, Bezos&#8217; commitment to &#8220;high-quality failures&#8221; and continuous experimentation paved the way for Amazon&#8217;s current dominance across multiple sectors.
According to the in-depth fundamental analysis by <a href="https://www.benzinga.com/insights/news/25/02/43914135/in-depth-analysis-amazon-com-versus-competitors-in-broadline-retail-industry">Benzinga Insights</a>, Amazon.com exhibits higher valuations than its broadline retail industry peers. 
<ul>
<li>Its price-to-earnings was at 39.16, 1.6x above the industry norm, price-to-book was at 8.03 relative to the industry average by 1.32x, and price-to-sales of 3.64 was 2.09x the industry average.</li>
</ul>
<ul>
<li>Higher P/E, P/B, and P/S ratios significantly exceed industry averages, though its ROE is slightly above average, indicating efficient equity use.</li>
</ul>
<ul>
<li>On the other hand, its EBITDA, gross profit, and revenue growth suggest strong financial performance and growth potential relative to industry competitors.</li>
</ul>
Price Action: Amazon fell 0.24% in premarket on Tuesday, contrasting with a 0.28% fall in the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the Nasdaq 100 index.
AMZN remains lower by 3.41% on a year-to-date basis and 1.74% over a year.
<a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">Benzinga tracks 43 analysts</a> with an average price target of $264.05 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $207 to $306. Recent ratings from Loop Capital, Citigroup, and Maxim Group average $279.33, suggesting a potential 32.07% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AMZN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="383" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-1024x383.png" alt="" class="wp-image-797284" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-1024x383.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-768x287.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR.png 1068w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43932776/mark-cuban-slams-fd-up-healthcare-system-blames-insurance-designed-deductibles-for-patient-bankruptcy">Mark Cuban Calls Deductibles &#8216;The Biggest Problem&#8217; in Healthcare: &#8216;System…Needs To Be Redesigned&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Markets

AMZN

Jeff Bezos Once Said 'Overnight Success' Takes 10 Years. It Took Amazon 25 Years To Surpass Walmart's Revenue

Travelzoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZOO#NASDAQ">TZOO</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.30 by 13.33 percent. This is a 8.33 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $20.68 million which missed the analyst consensus estimate of $22.06 million by 6.26 percent. This is a 2.23 percent decrease over sales of $21.15 million the same period last year.

Earnings Misses

TZOO

Travelzoo Q4 EPS $0.26 Misses $0.30 Estimate, Sales $20.68M Miss $22.06M Estimate

Management

DRVN

Driven Brands Announces COO Daniel Rivera Will Become President And CEO On May 9

Needham analyst Ryan MacDonald maintains Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) with a Buy and raises the price target from $31 to $61.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $61

For the full year 2025, we expect:
<ul>
<li>Total revenue of $870 to $890 million.</li>
<li>Adjusted EBITDA margin of 37% to 40%.</li>
<li>Adjusted free cash flow margin in the range of 16% to 18% of revenue.</li>
<li>Non-GAAP diluted net income per share of $1.85 to $1.95.</li>
<li>Fully diluted weighted average shares outstanding of approximately 104 to 105 million shares.</li>
</ul>

Guidance

DOCN

DigitalOcean Holdings Expects FY25 Revenue Of $870M-$890M Vs $877.56M Est, Adj EPS Of $1.85-$1.95 Vs $1.84 Est

LGI Homes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGIH#NASDAQ">LGIH</a>) reported quarterly earnings of $2.15 per share which missed the analyst consensus estimate of $2.43 by 11.52 percent. This is a 1.83 percent decrease over earnings of $2.19 per share from the same period last year. The company reported quarterly sales of $557.40 million which missed the analyst consensus estimate of $588.55 million by 5.29 percent. This is a 8.39 percent decrease over sales of $608.41 million the same period last year.

LGIH

LGI Homes Q4 GAAP EPS $2.15 Misses $2.43 Estimate, Sales $557.40M Miss $588.55M Estimate

Expro Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPRO#NYSE">XPRO</a>) For 2025, expect &nbsp;revenues to be stable to up modestly year-on-year

XPRO

Expro Gr Hldgs For 2025, expect  revenues to be stable to up modestly year-on-year

Citigroup analyst Daniel Grosslight maintains Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) with a Sell and raises the price target from $25 to $27.

Citigroup Maintains Sell on Hims & Hers Health, Raises Price Target to $27

Asset Sales

Driven Brands To Sell Its US Car Wash Business To Express Wash Operations, LLC dba Whistle Express Car Wash For $385M

<ul>
<li>Agreement will see Riyadh Air leverage IBM watsonx and&nbsp;IBM Consulting solutions to drive Riyadh Air's vision as the world's first digital native airline</li>
<li>The collaboration aims to help power the Saudi Arabian airline's mission to launch flights in 2025 while offering an elevated guest experience</li>
</ul>

Riyadh Air Taps IBM For AI Innovation, Aiming To Redefine Global Air Travel Standards

Expro Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPRO#NYSE">XPRO</a>) First quarter revenue is expected to be down sequentially by approximately 15% and relatively flat year-on-year

Expro Gr Hldgs First quarter revenue is expected to be down sequentially by approximately 15% and relatively flat year-on-year

HIMS: -20% &#x7C; <a href="https://www.benzinga.com//node/43935322">Hims &amp; Hers Health shares are trading lower after the company reported Q4 financial results.</a>
&nbsp;
TEM: -18% &#x7C; <a href="https://www.benzinga.com//node/43935332">Tempus AI shares are trading lower after the company reported Q4 financial results and missed revenue estimates.</a>
&nbsp;
RDHL: 34% &#x7C; <a href="https://www.benzinga.com//node/43936683">RedHill shares are trading higher after the company announced an exclusive licensing agreement with Hyloris Pharmaceuticals for RHB-102, including an upfront payment and up to $60 million in potential milestones.</a>

Movers

Trading Ideas

RDHL

Market-Moving News for February 25th

Financial Outlook:
DigitalOcean is initiating guidance for the first quarter ending March 31, 2025 as follows:
<ul>
<li>Total revenue of $207 to $209 million.</li>
<li>Adjusted EBITDA margin of 38% to 40%.</li>
<li>Non-GAAP diluted net income per share of $0.41 to $0.46.</li>
<li>Fully diluted weighted average shares outstanding of approximately 103 to 104 million shares.</li>
</ul>

DigitalOcean Holdings Expects Q1 Revenue Of $207M-$209M Vs $207.71M Est, Adj EPS Of $0.41-$0.46 Vs $0.42 Est

Minerva Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NERV#NASDAQ">NERV</a>) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(1.05) by 46.67 percent. This is a 52.94 percent increase over losses of $(1.19) per share from the same period last year.

NERV

Minerva Neurosciences Q4 2024 GAAP EPS $(0.56) Beats $(1.05) Estimate, Cash, Cash Equivalents And Restricted Cash At December 31, 2024, Were Approximately $21.5M

PLUG

Plug Power's Louisiana Hydrogen Plant Enters Final Commissioning Phase And Ready For Q1 Operations

HC Wainwright &amp; Co. analyst Arthur He reiterates Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) with a Buy and maintains $6.5 price target.

Reiteration

NKTR

HC Wainwright & Co. Reiterates Buy on Nektar Therapeutics, Maintains $6.5 Price Target

&nbsp;Gilat Satellite Networks Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILT#NASDAQ">GILT</a>, TASE: GILT)), a global leader in satellite networking technology, solutions, and services, today announced an investment of up to $3.5 million in Crosense, an early-stage startup revolutionizing drone detection and tracking. The investment is part of a funding round co-led by Frontier Capital, reinforcing strong industry confidence in Crosense's disruptive technology. This move aligns with Gilat's recently declared strategic focus on expanding its presence in the Homeland Security (HLS) and Defense sectors. &nbsp;

Comments

Range Capital Acquisition

Range Capital Acquisition (RANGU) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga